NEOSTIGMINE METHYLSULFATE

Generic: neostigmine methylsulfate

Labeler: Henry Schein, Inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive

Drug Facts

Product Profile

Brand Name NEOSTIGMINE METHYLSULFATE
Generic Name neostigmine methylsulfate
Labeler Henry Schein, Inc.
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

NEOSTIGMINE METHYLSULFATE 1 mg/mL

Identifiers & Regulatory

Product NDC 0404-9925
Product ID 0404-9925_ae929d69-7cc2-4ff8-86d2-15c3af1f6dca
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209933
Marketing Start 2022-01-13
Marketing End 2026-02-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04049925
Hyphenated Format 0404-9925

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name NEOSTIGMINE METHYLSULFATE (source: ndc)
Generic Name neostigmine methylsulfate (source: ndc)
Application Number ANDA209933 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 1 mg/mL
source: ndc
Packaging
  • 1 VIAL, MULTI-DOSE in 1 BAG (0404-9925-10) / 10 mL in 1 VIAL, MULTI-DOSE
source: ndc

Packages (1)

0404-9925-10 1 VIAL, MULTI-DOSE in 1 BAG (0404-9925-10) / 10 mL in 1 VIAL, MULTI-DOSE

Ingredients (1)

NEOSTIGMINE METHYLSULFATE (1 mg/mL)

Linked Drug Pages (1)

NEOSTIGMINE METHYLSULFATE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "ae929d69-7cc2-4ff8-86d2-15c3af1f6dca", "openfda": {"unii": ["98IMH7M386"], "rxcui": ["311936"], "spl_set_id": ["5f540e86-2a56-4cc0-8f69-64f051830a3d"], "manufacturer_name": ["Henry Schein, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 BAG (0404-9925-10)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "0404-9925-10", "marketing_end_date": "20260228", "marketing_start_date": "20220113"}], "brand_name": "NEOSTIGMINE METHYLSULFATE", "product_id": "0404-9925_ae929d69-7cc2-4ff8-86d2-15c3af1f6dca", "dosage_form": "INJECTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "0404-9925", "generic_name": "neostigmine methylsulfate", "labeler_name": "Henry Schein, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NEOSTIGMINE METHYLSULFATE", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": "1 mg/mL"}], "application_number": "ANDA209933", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20220113"}